For those that managed to stomach the stress of waiting out the stage 3 result, given the potential risk of failure and what that would have done to Neuren as a company, you’d think that from here the potential mid term outlook is far more palatable given the upside from so many more orphan drugs let alone the ROW rights for Trofinetide alone!
I was fully expecting to ride out the coming roller coaster share ride carrying my shares from the pre trial outcome days.
I never imagined that there would still be the opportunity to add to my holding at VERY reasonable levels!
At worst I hope to double my return on recent shares purchased with minimal risk.
Reverting to BUY from hold.
Good luck longs/mids and traders from here.
Where to in 2021?, page-21
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.59 |
Change
0.380(2.50%) |
Mkt cap ! $1.992B | |||
| Open | High | Low | Value | Volume |
| $15.51 | $15.82 | $15.46 | $11.26M | 722.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 696 | $15.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.67 | 6942 | 8 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |